EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products

Agnieszka Stawarska iD, Magdalena Bamburowicz-Klimkowska iD, Elise Runden-Pran iD, Maria Dusinska iD, Mihaela Roxana Cimpan, Ivan Rios-Mondragon iD, Ireneusz P Grudzinski iD

International Journal of Molecular Sciences · 13.06.2024 · 25 (12) · 6533

DOI: 10.3390/ijms25126533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2024. Verfasst von Agnieszka Stawarska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Banacha Str. 1, 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development, Norwegian Financial Mechanisms 2014–2021/POLNOR 2019 (EEA and Norway Grants).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) hold great promise for clinical application as new diagnostic and therapeutic modalities. This paper describes major GMP-based upstream and downstream manufacturing processes for EV large-scale production, also focusing on post-processing technologies such as surface bioengineering and uploading studies to yield novel EV-based diagnostics and advanced therapy medicinal products. This paper also focuses on the quality, safety, and efficacy issues of the bioengineered EV drug candidates before first-in-human studies. Because clinical trials involving extracellular vesicles are on the global rise, this paper encompasses different clinical studies registered on clinical-trial register platforms, with varying levels of advancement, highlighting the growing interest in EV-related clinical programs. Navigating the regulatory affairs of EVs poses real challenges, and obtaining marketing authorization for EV-based medicines remains complex due to the lack of specific regulatory guidelines for such novel products. This paper discusses the state-of-the-art regulatory knowledge to date on EV-based diagnostics and medicinal products, highlighting further research and global regulatory needs for the safe and reliable implementation of bioengineered EVs as diagnostic and therapeutic tools in clinical settings. Post-marketing pharmacovigilance for EV-based medicinal products is also presented, mainly addressing such topics as risk assessment and risk management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesHumansAnimals

Stichwörter der Autor:innen

GMP manufacturingclinical trialsdiagnosticsextracellular vesiclesmedicinal productspreclinical studiesregulatory affairs

Autor:innen und Institutionen

  • Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Banacha Str. 1, 02-097 Warsaw, Poland.
  • Health Effects Laboratory, Department of Environmental Chemistry, Norwegian Institute for Air Research, 2007 Kjeller, Norway.
  • Biomaterials-Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Årstadveien Str. 19, 5009 Bergen, Norway.

ORCID-Profile: Agnieszka Stawarska, Magdalena Bamburowicz-Klimkowska, Elise Runden-Pran, Maria Dusinska, Ivan Rios-Mondragon, Ireneusz P Grudzinski

Förderung

  • National Centre for Research and Development
  • Norwegian Financial Mechanisms 2014–2021/POLNOR 2019 (EEA and Norway Grants)

Zitieren

APA

Stawarska, A., Bamburowicz-Klimkowska, M., Runden-Pran, E., Dusinska, M., Cimpan, M. R., Rios-Mondragon, I., & Grudzinski, I. P. (2024). Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products. International Journal of Molecular Sciences, 25(12), 6533. https://doi.org/10.3390/ijms25126533

Vancouver

Stawarska A, Bamburowicz-Klimkowska M, Runden-Pran E, Dusinska M, Cimpan MR, Rios-Mondragon I, et al. Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products. International Journal of Molecular Sciences. 2024;25(12):6533. doi:10.3390/ijms25126533

BibTeX
@article{Stawarska2024,
  author = {Stawarska, Agnieszka and Bamburowicz-Klimkowska, Magdalena and Runden-Pran, Elise and Dusinska, Maria and Cimpan, Mihaela Roxana and Rios-Mondragon, Ivan and Grudzinski, Ireneusz P},
  title = {Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6533},
  doi = {10.3390/ijms25126533}
}
Kostenlos starten →